Safety and efficacy of eniluracil + capecitabine (6422 + Cap) in phase 1b trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results